Induction of autophagy via the TLR4/NF-κB signaling pathway by astragaloside Ⅳ contributes to the amelioration of inflammation in RAW264.7 cells
Cigarette smoking-related lung injury is one of the most common and fatal etiologies of many respiratory diseases, for which no effective interventions are available. Astragaloside Ⅳ (ASⅣ) is an active component extracted from Astragalus membranaceus. It is prescribed as a treatment for upper respir...
Main Authors: | Yi Ying, Chun-bin Sun, Si-qi Zhang, Bo-jun Chen, Jing-ze Yu, Fei-yu Liu, Jing Wen, Jiong Hou, Si-si Han, Jin-yuan Yan, Zhong-shan Yang, Lei Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221000561 |
Similar Items
-
Protective Effects of Astragaloside IV against LPS-Induced Endometritis in Mice through Inhibiting Activation of the NF-κB, p38 and JNK Signaling Pathways
by: Fengge Wang, et al.
Published: (2019-01-01) -
Astragaloside IV protects neurons from microglia-mediated cell damage through promoting microglia polarization
by: Jingwen Yu, et al.
Published: (2019-06-01) -
Astragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB P65 subunit
by: Wang X, et al.
Published: (2018-09-01) -
Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
by: Li-Fei Luo, et al.
Published: (2021-05-01) -
An updated role of astragaloside IV in heart failure
by: Yibei Zang, et al.
Published: (2020-06-01)